The Improvement of the Dissolution Rate of Ziprasidone Free Base from Solid Oral Formulations

Journal Title: AAPS PharmSciTech - Year 2015, Vol 16, Issue 4

Abstract

This work aims at increasing solubility and dissolution rate of ziprasidone free base—Biopharmaceutics Classifaction System (BCS) class II compound. The authors describe a practical approach to amorphization and highlight problems that may occur during the development of formulations containing amorphous ziprasidone, which was obtained by grinding in high-energy planetary ball mills or cryogenic mills. The release of ziprasidone free base from the developed formulations was compared to the reference drug product containing crystalline ziprasidone hydrochloride—Zeldox® hard gelatin capsules. All preparations were investigated using compendial tests (USP apparatuses II and IV) as well as novel, biorelevant dissolution tests. The novel test methods simulate additional elements of mechanical and hydrodynamic stresses, which have an impact on solid oral dosage forms, especially during gastric emptying. This step may prove to be particularly important for many formulations of BCS class II drugs that are often characterized by narrow absorption window, such as ziprasidone. The dissolution rate of the developed ziprasidone free base preparations was found to be comparable or even higher than in the case of the reference formulation containing ziprasidone hydrochloride, whose water solubility is about 400 times higher than its free base.

Authors and Affiliations

Daniel Zakowiecki, Krzysztof Cal, Kamil Kaminski, Karolina Adrjanowicz, Lech Swinder, Ewa Kaminska, Grzegorz Garbacz

Keywords

Related Articles

Encapsulation of Mentha Oil in Chitosan Polymer Matrix Alleviates Skin Irritation

The online version of this article (doi:10.1208/s12249-015-0378-x) contains supplementary material, which is available to authorized users.

Influence of Process Parameters on Tablet Bed Microenvironmental Factors During Pan Coating

Recent studies have shown the importance of monitoring microenvironmental conditions (temperature, relative humidity) experienced by the tablet bed during a pan coating process, thereby necessitating the need to understa...

Drop-on-Demand System for Manufacturing of Melt-based Solid Oral Dosage: Effect of Critical Process Parameters on Product Quality

The features of a drop-on-demand-based system developed for the manufacture of melt-based pharmaceuticals have been previously reported. In this paper, a supervisory control system, which is designed to ensure reproducib...

Controlled Extraction Studies Applied to Polyvinyl Chloride and Polyethylene Materials: Conclusions from the ELSIE Controlled Extraction Pilot Study

The effective management of leachables in pharmaceutical products is a critical aspect of their development. This can be facilitated if extractables information on the materials used in a packaging or delivery system is...

Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation

The influence of formulation variables, i.e., a hydrophilic polymer (Methocel® E15) and a film-forming polymer (Eudragit® RL 100 and Eudragit® RS 100), on the physicochemical and functional proper...

Download PDF file
  • EP ID EP682269
  • DOI  10.1208/s12249-015-0285-1
  • Views 72
  • Downloads 0

How To Cite

Daniel Zakowiecki, Krzysztof Cal, Kamil Kaminski, Karolina Adrjanowicz, Lech Swinder, Ewa Kaminska, Grzegorz Garbacz (2015). The Improvement of the Dissolution Rate of Ziprasidone Free Base from Solid Oral Formulations. AAPS PharmSciTech, 16(4), -. https://europub.co.uk/articles/-A-682269